Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the 68Ga- and 177Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi)2.

Autor:	Läppchen, Tilman1 (AUTHOR) tilman.laeppchen@insel.ch, Bilinska, Adrianna1 (AUTHOR) adrianna.bilinska@extern.insel.ch, Pilatis, Eirinaios1 (AUTHOR) eirinaios.pilatis@insel.ch, Menéndez, Elena1 (AUTHOR) elena.menendez@insel.ch, Imlimthan, Surachet1 (AUTHOR) surachet.imlimthan@helsinki.fi, Moon, Euy Sung2 (AUTHOR) esmoon92@googlemail.com, Afshar-Oromieh, Ali1 (AUTHOR) ali.afshar@insel.ch, Rösch, Frank2 (AUTHOR) froesch@uni-mainz.de, Rominger, Axel1 (AUTHOR) axel.rominger@insel.ch, Gourni, Eleni1 (AUTHOR) eleni.gourni@insel.ch
Zdroj:	Molecules. Jul2024, Vol. 29 Issue 13, p1-17. 17p. 3 Color Photographs, 1 Diagram, 1 Chart, 8 Graphs.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu